Skip to main content
News   »   Eir Ventures completes investment in ArgusEye

Eir Ventures completes investment in ArgusEye

6 Dec, 2021 | Press Releases
Download Press Release

Eir Ventures today announced the completion of an investment in ArgusEye, a biotechnology company developing sensor solutions for real-time detection of biological systems and processes.

All news articles
Eir Ventures Invests in Purpose Pharma
5 Sep, 2024
Hoba Therapeutics raises EUR 23 million
11 Dec, 2023
Eir Ventures invests in Dania Tx
18 Oct, 2023
Eir Ventures celebrates 3 years anniversary
10 Jul, 2023
Lovisa Bacekmar new Principal
9 Jul, 2023
Eir invests in RAPP
9 May, 2023
Eir invests in GutCRINE
11 Apr, 2023
Eir Ventures leads €28M investment in Scenic Biotec
10 Mar, 2023
Eir Ventures invests in Henlez
25 Oct, 2022
Eir Ventures portfolio company, Pretzel Therapeutics, announces USD 72,5m series A financing
14 Sep, 2022
Eir Ventures invests in Hoba Therapeutics
6 Jul, 2022
Eir Ventures joins oversubscribed investment round in Attgeno
1 Jul, 2022
Eir Ventures strengthens team – appoints three new Partners
3 Jun, 2022
Eir Ventures joins oversubscribed investment round in Cinclus Pharma
21 May, 2022
Eir Ventures today announced the completion of an investment in Strike Pharma
23 Feb, 2022
Eir Ventures announces Co-investment agreement with Copenhagen University
26 Jan, 2022
Eir Ventures is happy to welcome two interns
5 Jan, 2022
Eir Ventures expands team with new principal
20 Dec, 2021
Eir Ventures Closes Life Science Venture Fund at EUR122 million
9 Dec, 2021
Eir Ventures completes investment in ArgusEye
6 Dec, 2021
Eir Ventures upscales with Investment Associate
23 Nov, 2021
Eir Ventures’ first “seedling” Synklino ApS completes oversubscribed DKK 106 million series A round
15 Nov, 2021
IO Biotech, Inc. Announces Pricing of Initial Public Offering
5 Nov, 2021
Galecto Announces Clinical Collaboration with Roche
3 Nov, 2021
Eir Ventures completes investment in one-carbon Therapeutics.
26 Oct, 2021